OOIR: Observatory of International Research

Papers

(The H4-Index of Oncoimmunology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Identification of pyroptosis-related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in colorectal cancer	75
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer	71
PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity	53
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer	52
Ferroptosis becomes immunogenic: implications for anticancer treatments	52
Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies	52
Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment	49
Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer	49
YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non–small-cell lung cancer	48
YKT6 , as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration	45
Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer	45
IFN-γ-induced ER stress impairs autophagy and triggers apoptosis in lung cancer cells	45
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma	40
Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression	38
Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity	38
Integrated analyses of m ¹ A regulator-mediated modification patterns in tumor microenvironment-infiltrating immune cells in colon cancer	36
Construction of PD1/CD28 chimeric-switch receptor enhances anti-tumor ability of c-Met CAR-T in gastric cancer	33
TIGIT ⁺ TIM-3 ⁺ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related	33
Tumors exploit CXCR4 ^hi CD62L ^lo aged neutrophils to facilitate metastatic spread	33
The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis	33
Gas plasma irradiation of breast cancers promotes immunogenicity, tumor reduction, and an abscopal effect in vivo	32
Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study	32
Trial watch: intratumoral immunotherapy	31
Association between immune-related adverse event timing and treatment outcomes	31
Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients	31

Comprehensive analyses reveal TKI-induced remodeling of the tumor immune microenvironment in EGFR/ALK-positive non-small-cell lung cancer	30
Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis	30
Tumor-intrinsic determinants of immunogenic cell death modalities	30
LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells	30
Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma	29
Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in lung adenocarcinoma	29
Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors	29